Freestone Grove Partners LP Elanco Animal Health Inc Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Freestone Grove Partners LP holds 3,851,050 shares of ELAN stock, worth $83.6 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
3,851,050
Previous 3,207,335
20.07%
Holding current value
$83.6 Million
Previous $33.7 Billion
63.3%
% of portfolio
0.42%
Previous 0.35%
Shares
3 transactions
Others Institutions Holding ELAN
# of Institutions
421Shares Held
484MCall Options Held
868KPut Options Held
1.42M-
Dodge & Cox San Francisco, CA82.9MShares$1.8 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$1.12 Billion0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA47.8MShares$1.04 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$506 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$494 Million0.08% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10.3B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...